CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 13 | -100.0% | 0.00% | -100.0% |
Q1 2022 | $1,182,000 | -42.9% | 60,300 | -0.1% | 0.00% | -50.0% |
Q4 2021 | $2,070,000 | -37.3% | 60,335 | -0.2% | 0.00% | -50.0% |
Q3 2021 | $3,303,000 | -24.9% | 60,476 | +1.0% | 0.00% | -20.0% |
Q2 2021 | $4,401,000 | – | 59,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 3,134,780 | $107,600,000 | 32.65% |
Affinity Asset Advisors, LLC | 50,000 | $1,716,000 | 0.62% |
Renaissance Capital LLC | 21,659 | $743,000 | 0.19% |
Eversept Partners, LP | 85,017 | $2,916,933 | 0.19% |
TWINBEECH CAPITAL LP | 67,504 | $2,316,000 | 0.13% |
Alpine Global Management, LLC | 23,033 | $790,000 | 0.12% |
Paradigm Financial Advisors, LLC | 13,535 | $464,000 | 0.10% |
Caption Management, LLC | 200,000 | $6,860,000 | 0.08% |
Baillie Gifford | 3,923,340 | $134,610,000 | 0.07% |
Donoghue Forlines LLC | 11,570 | $397,000 | 0.07% |